These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8023850)

  • 1. Canavan disease: mutations among Jewish and non-Jewish patients.
    Kaul R; Gao GP; Aloya M; Balamurugan K; Petrosky A; Michals K; Matalon R
    Am J Hum Genet; 1994 Jul; 55(1):34-41. PubMed ID: 8023850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease.
    Zeng BJ; Wang ZH; Ribeiro LA; Leone P; De Gasperi R; Kim SJ; Raghavan S; Ong E; Pastores GM; Kolodny EH
    J Inherit Metab Dis; 2002 Nov; 25(7):557-70. PubMed ID: 12638939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease.
    Kaul R; Gao GP; Matalon R; Aloya M; Su Q; Jin M; Johnson AB; Schutgens RB; Clarke JT
    Am J Hum Genet; 1996 Jul; 59(1):95-102. PubMed ID: 8659549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution.
    Kaul R; Balamurugan K; Gao GP; Matalon R
    Genomics; 1994 May; 21(2):364-70. PubMed ID: 8088831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel splice site mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
    Rady PL; Penzien JM; Vargas T; Tyring SK; Matalon R
    Eur J Paediatr Neurol; 2000; 4(1):27-30. PubMed ID: 10701101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency of the C854 mutation in the aspartoacylase gene in Ashkenazi Jews in Israel.
    Elpeleg ON; Anikster Y; Barash V; Branski D; Shaag A
    Am J Hum Genet; 1994 Aug; 55(2):287-8. PubMed ID: 8037206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation detection in the aspartoacylase gene in 17 patients with Canavan disease: four new mutations in the non-Jewish population.
    Sistermans EA; de Coo RF; van Beerendonk HM; Poll-The BT; Kleijer WJ; van Oost BA
    Eur J Hum Genet; 2000 Jul; 8(7):557-60. PubMed ID: 10909858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canavan disease: diagnosis and molecular analysis.
    Matalon R
    Genet Test; 1997; 1(1):21-5. PubMed ID: 10464621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canavan disease: a novel mutation.
    Schober H; Luetschg J; Hoeliner I; Kalb S; Simma B
    Pediatr Neurol; 2011 Oct; 45(4):256-8. PubMed ID: 21907889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of canavan (aspartoacylase deficiency) disease in European non-Jewish patients.
    Shaag A; Anikster Y; Christensen E; Glustein JZ; Fois A; Michelakakis H; Nigro F; Pronicka E; Ribes A; Zabot MT
    Am J Hum Genet; 1995 Sep; 57(3):572-80. PubMed ID: 7668285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-Jewish patients.
    Elpeleg ON; Shaag A
    J Inherit Metab Dis; 1999 Jun; 22(4):531-4. PubMed ID: 10407784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spongy degeneration of the brain, Canavan disease: biochemical and molecular findings.
    Matalon RM; Michals-Matalon K
    Front Biosci; 2000 Mar; 5():D307-11. PubMed ID: 10704428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of a DNA polymorphism at position Y231 in the aspartoacylase gene and its impact on DNA-based carrier testing for Canavan disease in the Ashkenazi Jewish Population.
    Alford RL; DeMarchi JM; Richards CS
    Hum Mutat; 1998; Suppl 1():S161-2. PubMed ID: 9452075
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel mutation in an Egyptian patient with infantile Canavan disease.
    Zaki OK; El Abd HS; Mohamed SA; Zayed H
    Metab Brain Dis; 2016 Jun; 31(3):573-7. PubMed ID: 26613958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease.
    Kaul R; Gao GP; Balamurugan K; Matalon R
    Nat Genet; 1993 Oct; 5(2):118-23. PubMed ID: 8252036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel aspartoacylase (ASPA) gene mutation in Canavan disease.
    Durmaz AA; Akin H; Onay H; Vahabi A; Ozkinay F
    Fetal Pediatr Pathol; 2012 Aug; 31(4):236-9. PubMed ID: 22468686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier screening for Canavan disease in Australia.
    Howell VM; Proos AL; LaRue D; Jensen CH; Beach F; Burnett L
    J Inherit Metab Dis; 2004; 27(2):289-90. PubMed ID: 15243987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canavan disease: an Arab scenario.
    Zayed H
    Gene; 2015 Apr; 560(1):9-14. PubMed ID: 25668701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of the aspartoacylase gene in non-Jewish patients with Canavan disease.
    Zeng BJ; Pastores GM; Leone P; Raghavan S; Wang ZH; Ribeiro LA; Torres P; Ong E; Kolodny EH
    Adv Exp Med Biol; 2006; 576():165-73; discussion 361-3. PubMed ID: 16802711
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
    Unalp A; Altiok E; Uran N; Oztürk A; Yüksel S
    J Trop Pediatr; 2008 Jun; 54(3):208-10. PubMed ID: 17999961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.